Anti-SARS-CoV-2 Spike RBD (CB6 biosimilar) Neutralizing Antibody, IgG1, Unconjugated, Human

Produktübersicht

• Artikelname: Anti-SARS-CoV-2 Spike RBD (CB6 biosimilar) Neutralizing Antibody, IgG1, Unconjugated, Human
• Artikelnummer: RDD-RD90429A
• Hersteller Artikelnummer: RD90429A
• Alternativnummer: RDD-RD90429A-50,RDD-RD90429A-100,RDD-RD90429A-200
• Hersteller: reddot Biotech
• Wirt: Human
• Kategorie: Antikörper
• Applikation: ELISA, NeA
• Spezies Reaktivität: Virus
• Konjugation: Unconjugated
• Alternative Synonym: coronavirus s1,coronavirus s2,coronavirus spike,cov spike,ncov RBD,ncov s1,ncov s2,ncov spike,novel coronavirus RBD,novel coronavirus s1,novel coronavirus s2,novel coronavirus spike,RBD,S1,s2,Spike RBD

Produktbeschreibung

This is a Anti-SARS-CoV-2 Spike RBD (CB6 biosimilar) Neutralizing Virus Antibody from Reddot Biotech. This product is for Research Use Only.

Produkteigenschaften

• Konzentration: 0.79 mg/mL
• Isotyp: IgG1
• Puffer: PBS, pH 7.4, 10% glycerol

Bilder

Immobilized Recombinant 2019-nCoV Spike Protein (RBD, C-mFc Tag)(Active) at 2.0 ug/mL (100 uL/well) can bind Anti-SARS-CoV-2 Spike RBD (CB6 biosimilar) Neutralizing Antibody in a linear range of 0.24~15.62 ng/mL.

Competition assay demonstrating CB6 blocked of SARS-COV-2 RBD binding to HEK293 transfected ACE2 cells in FCAS-based assay. IC50=789.3 ng/mL.

Antibodies from Reddot Biotech